72 related articles for article (PubMed ID: 1332634)
21. The effect of hormone replacement therapy on arterial blood pressure and vascular compliance in postmenopausal women with arterial hypertension.
Kawecka-Jaszcz K; Czarnecka D; Olszanecka A; Rajzer M; Jankowski P
J Hum Hypertens; 2002 Jul; 16(7):509-16. PubMed ID: 12080436
[TBL] [Abstract][Full Text] [Related]
22. The effects of estrogen therapy and estrogen combined with different androgenic progestins on carbohydrate and lipid metabolism in overweight-obese younger postmenopausal women.
Demir B; Ozturkoglu E; Solaroglu A; Baskan B; Kandemir O; Karabulut E; Haberal A
Gynecol Endocrinol; 2008 Jun; 24(6):347-53. PubMed ID: 18584415
[TBL] [Abstract][Full Text] [Related]
23. Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate or with 17beta-estradiol and norethindrone acetate.
Odmark IS; Jonsson B; Bäckström T
Am J Obstet Gynecol; 2001 May; 184(6):1131-8. PubMed ID: 11349178
[TBL] [Abstract][Full Text] [Related]
24. Intranasal continuous combined 17 beta-estradiol/norethisterone therapy improves the lipid profile in healthy postmenopausal women.
Hemelaar M; Kenemans P; de Bie L; van de Weijer PH; van der Mooren MJ
Fertil Steril; 2006 Apr; 85(4):979-88. PubMed ID: 16580384
[TBL] [Abstract][Full Text] [Related]
25. Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy.
Sørensen MB; Rosenfalck AM; Højgaard L; Ottesen B
Obes Res; 2001 Oct; 9(10):622-6. PubMed ID: 11595778
[TBL] [Abstract][Full Text] [Related]
26. Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
Osmanağaoğlu MA; Osmanağaoğlu S; Osmanağaoğlu T; Okumuş B; Bozkaya H
Fertil Steril; 2005 Aug; 84(2):384-93. PubMed ID: 16084879
[TBL] [Abstract][Full Text] [Related]
27. The metabolic and bone density effects of continuous combined 17-beta estradiol and noresthisterone acetate treatments in Thai postmenopausal women: a double-blind placebo-controlled trial.
Bunyavejchevin S; Limpaphayom KK
J Med Assoc Thai; 2001 Jan; 84(1):45-53. PubMed ID: 11281499
[TBL] [Abstract][Full Text] [Related]
28. [Hormone replacement therapy in women with arterial hypertension in peri- and postmenopause: hemodynamic effects].
Bystrova MM; Britov AN; Gorbunov VM; Lebedev AV; Eliseeva NA; Smetnik VP; Slasten OP
Ter Arkh; 2001; 73(10):33-8. PubMed ID: 11763512
[TBL] [Abstract][Full Text] [Related]
29. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause.
Jensen J; Christiansen C; Rødbro P
N Engl J Med; 1985 Oct; 313(16):973-5. PubMed ID: 4047104
[TBL] [Abstract][Full Text] [Related]
30. Estrogen and comprehension of metaphoric speech in women suffering from schizophrenia: results of a double-blind, placebo-controlled trial.
Bergemann N; Parzer P; Jaggy S; Auler B; Mundt C; Maier-Braunleder S
Schizophr Bull; 2008 Nov; 34(6):1172-81. PubMed ID: 18156639
[TBL] [Abstract][Full Text] [Related]
31. Continuous combined and sequential estradiol and norethindrone acetate treatment of postmenopausal women: effect of plasma lipoproteins in a two-year placebo-controlled trial.
Munk-Jensen N; Ulrich LG; Obel EB; Nielsen SP; Edwards D; Meinertz H
Am J Obstet Gynecol; 1994 Jul; 171(1):132-8. PubMed ID: 8030688
[TBL] [Abstract][Full Text] [Related]
32. Effect on lipoproteins of Trisequens, a combined hormone preparation.
Fletcher CD; Farish E; Hart DM; Leggate J; Clark DM; Kitchener H; Sharpe GL
Maturitas; 1984 Nov; 6(3):279-83. PubMed ID: 6595494
[TBL] [Abstract][Full Text] [Related]
33. Effect of hormone replacement therapy on cardiovascular risk factors in postmenopausal women with diabetes.
Scott AR; Dhindsa P; Forsyth J; Mansell P;
Diabetes Obes Metab; 2004 Jan; 6(1):16-22. PubMed ID: 14686958
[TBL] [Abstract][Full Text] [Related]
34. [Evaluation of hormone therapy in women during postmenopause with the help of Kliogest].
Bałajewicz M; Mazanek-Mościcka M
Ginekol Pol; 1996 Nov; 67(11):561-8. PubMed ID: 9289443
[TBL] [Abstract][Full Text] [Related]
35. [Kliogest--the possibility of hormonal substitution in the postmenopause].
Rachev E
Akush Ginekol (Sofiia); 1993; 32(3):64-6. PubMed ID: 8037328
[TBL] [Abstract][Full Text] [Related]
36. The endometrial status of women on long-term continuous combined hormone replacement therapy.
Hawthorn RJ; Spowart K; Walsh D; Hart DM
Br J Obstet Gynaecol; 1991 Sep; 98(9):939-40. PubMed ID: 1911615
[No Abstract] [Full Text] [Related]
37. Differing effects of oral and transdermal hormone replacement therapy on cardiovascular risk factors in healthy postmenopausal women.
Strandberg TE; Ylikorkala O; Tikkanen MJ
Am J Cardiol; 2003 Jul; 92(2):212-4. PubMed ID: 12860228
[No Abstract] [Full Text] [Related]
38. Postmenopausal hormone replacement therapy and plasma lipoproteins.
Taskinen MR
J Intern Med; 1995 Nov; 238(5):385-7. PubMed ID: 7595177
[No Abstract] [Full Text] [Related]
39. Does 1,25(OH)2D3 accelerate spinal bone loss? A controlled therapeutic trial in 70-year-old women.
Jensen GF; Meinecke B; Boesen J; Transbøl I
Clin Orthop Relat Res; 1985; (192):215-21. PubMed ID: 3881203
[TBL] [Abstract][Full Text] [Related]
40. The effect of estrogen therapy on somatic and psychical symptoms in postmenopausal women.
Furuhjelm M; Karlgren E; Carlström K
Acta Obstet Gynecol Scand; 1984; 63(7):655-61. PubMed ID: 6440406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
